Sara Giordano

Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones

Felice Iasevoli, Sara Giordano, Raffaele Balletta et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2015 · 175 citations

Medicine, Psychiatry, Psychology +12

Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses

Andrea de Bartolomeis, Raffaele Balletta, Sara Giordano et al. · Psychiatry Research · 2013 · 84 citations

Medicine, Psychiatry, Psychology +13

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)

Virginia Kaklamani, Jacqueline S. Jeruss, Elisha Hughes et al. · Breast Cancer Research and Treatment · 2015 · 74 citations

Medicine, Oncology, Breast Oncology +13

Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment

Felice Iasevoli, Raffaele Balletta, Valentina Gilardi et al. · Neuropsychiatric Disease and Treatment · 2013 · 60 citations · Full text

Medicine, Psychiatry, Psychology +17

Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach

Annarita Barone, Michele De Prisco, Benedetta Altavilla et al. · Journal of Psychiatric Research · 2022 · 22 citations

Medicine, Psychiatry, Psychology +16